Skip to main content
. 2019 Jan 9;74(4):944–952. doi: 10.1093/jac/dky546

Table 1.

MIC90 of apramycin in comparison with gentamicin and amikacin against clinical isolates of Enterobacteriaceae and A. baumannii isolated between 2014 and 2017

MIC90 (mg/L)
Species No. APR GEN AMK
Enterobacteriaceae (all) 1132 8 >64 >64
 Escherichia coli 250 8 >64 >64
 Klebsiella pneumoniae 372 4 >64 >64
 Enterobacter spp. 179 4 >64 >64
 Morganella morganii 37 8 >64 4
 Citrobacter freundii 131 8 >64 >64
 Providencia spp. 80 8 >64 >64
 Proteus mirabilis 32 8 >64 >64
 Serratia marcescens 51 8 >64 >64
CPE only (all) 406 4 >128 >128
 Escherichia coli 74 8 >128 >128
 Klebsiella pneumoniae 236 4 >128 >128
 Enterobacter spp. 48 8 >128 >128
 Citrobacter freundii 48 4 >128 >128
A. baumannii 100 16 >64 >64
CPA only 17 16 >256 >256
Geographic origin
 Europe 799 8 >64 >64
 Asia 240 8 >256 >256
 Africa 107 8 >256 >256
 South America 86 4 >256 >256

APR, apramycin; AMK, amikacin; GEN, gentamicin; CPE, carbapenemase-producing Enterobacteriaceae; CPA, carbapenemase-producing A. baumannii.